Acima Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Acima Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$860K	Sell	1,644 -162	-9%	-$83K	0.25%	54
2026 Q2	$897K	Hold	1,806	–	–	0.26%	53
2026 Q1	$806K	Hold	1,806	–	–	0.25%	57
2025 Q4	$819K	Hold	1,806	–	–	0.25%	57
2025 Q3	$707K	Hold	1,806	–	–	0.22%	61
2025 Q2	$804K	Hold	1,806	–	–	0.27%	57
2025 Q1	$876K	Hold	1,806	–	–	0.31%	50
2024 Q4	$727K	Sell	1,806 -1,275	-41%	-$591K	0.24%	63
2024 Q3	$1.43M	Hold	3,081	–	–	0.48%	43
2024 Q2	$1.44M	Hold	3,081	–	–	0.53%	40
2024 Q1	$1.29M	Hold	3,081	–	–	0.47%	47
2023 Q4	$1.25M	Hold	3,081	–	–	0.49%	46
2023 Q3	$1.07M	Sell	3,081 -299	-9%	-$105K	0.48%	52
2023 Q2	$1.19M	Sell	3,380 -58	-2%	-$19.5K	0.57%	46
2023 Q1	$1.08M	Hold	3,438	–	–	0.53%	49
2022 Q4	$993K	Sell	3,438 -401	-10%	-$122K	0.51%	53
2022 Q3	$1.11M	Hold	3,839	–	–	0.57%	46
2022 Q2	$1.08M	Hold	3,839	–	–	0.54%	49
2022 Q1	$1M	Hold	3,839	–	–	0.46%	54
2021 Q4	$843K	Hold	3,839	–	–	0.36%	66
2021 Q3	$696K	Hold	3,839	–	–	0.32%	73
2021 Q2	$774K	Hold	3,839	–	–	0.36%	68
2021 Q1	$825K	Hold	3,839	–	–	0.41%	62
2020 Q4	$907K	Hold	3,839	–	–	0.47%	59
2020 Q3	$1.04M	Sell	3,839 -16	-0.4%	-$4.41K	0.63%	45
2020 Q2	$1.12M	Hold	3,855	–	–	0.72%	40
2020 Q1	$917K	Hold	3,855	–	–	0.71%	36
2019 Q4	$844K	Hold	3,855	–	–	0.58%	43
2019 Q3	$653K	Hold	3,855	–	–	0.5%	48
2019 Q2	$707K	Hold	3,855	–	–	0.56%	43
2019 Q1	$709K	Buy	3,855 +16	+0.4%	+$2.96K	0.61%	39
2018 Q4	$636K	Buy	+3,839	New	+$665K	0.62%	39

Other funds holding VRTX

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

VWM

Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GGS

Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

LJHT

Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return

CFG

Cooper Financial Group Irvine, California $1.26B AUM 21.18% 1-Year Est. Return

Acima Private Wealth's VRTX Position: Q3 2026 in Review

Acima Private Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 9% in Q3 2026, selling an estimated $83K and leaving 1,644 shares worth $860K. The position accounts for 0.25% of the portfolio, ranked #54.

Acima Private Wealth first reported a position in VRTX in Q4 2018 and has held it in 32 quarters since. The position peaked at $1.44M in Q2 2024. 66 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Acima Private Wealth held 1,644 shares of Vertex Pharmaceuticals worth $860K as of Q3 2026.
Acima Private Wealth sold 162 Vertex Pharmaceuticals shares in Q3 2026, an estimated $83K.
Vertex Pharmaceuticals made up 0.25% of Acima Private Wealth's portfolio in Q3 2026, its #54 holding.
Acima Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 32 quarters since.
Acima Private Wealth's Vertex Pharmaceuticals position peaked at $1.44M in Q2 2024.
66 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Acima Private Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.